专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06576927B2 Semiconductor device and GaN-based field effect transistor for use in the same 有权
标题翻译：半导体器件和GaN基场效应晶体管用于相同
公开(公告)号：US06576927B2
公开(公告)日：2003-06-10
申请号：US10084717
申请日：2002-02-25
申请人： Seikoh Yoshida , Hironari Takehara , Takahiro Wada
发明人： Seikoh Yoshida , Hironari Takehara , Takahiro Wada
IPC分类号： H01L2976
CPC分类号： H01L29/66924 , H01L29/2003 , H01L29/66863 , H01L29/802 , H01L29/812
摘要： The present invention provides a semiconductor device as an FET integrated object having a small effective area, a small ON resistance during operation, a high voltage resistance, and capable of large-current drive. This device comprises one or more FET's each having a gate electrode, a source electrode, and a drain electrode, and arranged side by side on a single plane to constitute a first block which is stacked on a second block having a configuration identical to the first block, wherein the gate electrode, the source electrode, and the drain electrode of the FET(s) of the first block are directly joined with the gate electrode, the source electrode, and the drain electrode of the FET(s) of the second block, respectively.
摘要翻译：本发明提供一种作为FET集成物体的半导体器件，其具有小的有效面积，在操作期间的小导通电阻，高电压电阻并且能够进行大电流驱动。该器件包括一个或多个FET，每个FET具有栅电极，源电极和漏电极，并排设置在单个平面上，以构成第一块，该第一块堆叠在第二块上，该第二块具有与第一块相同的构造块，其中第一块的FET的栅电极，源电极和漏电极与第二块的FET的栅电极，源电极和漏电极直接接合块。

2. 发明授权

US06897495B2 Field effect transistor and manufacturing method therefor 有权
标题翻译：场效应晶体管及其制造方法
公开(公告)号：US06897495B2
公开(公告)日：2005-05-24
申请号：US10270708
申请日：2002-10-11
申请人： Seikoh Yoshida , Takahiro Wada , Hironari Takehara
发明人： Seikoh Yoshida , Takahiro Wada , Hironari Takehara
IPC分类号： H01L21/285 , H01L29/20 , H01L29/80 , H01L31/0328 , H01L31/0336
CPC分类号： H01L21/28575 , H01L29/2003 , H01L29/802
摘要： GaN-based FET has a sapphire substrate of about 50 nm thick on which an n-type GaN electron transit layer and an Al0.2Gao0.8N electron supply layer are formed, together with n+-type GaN contact regions sandwiching the electron transit and supply layers therebetween. On the entire faces of these layer and regions is formed a polyimide interlayer insulating film of about 3000 nm thick that is formed with contact holes in which source, drain and gate electrodes are formed, each of which is comprised of a TaSi/Au layer and about 5000 nm in thickness. The source and drain electrodes are ohmic-connected to the n+-type GaN contact regions and the gate electrode is in contact with an SiO2 gate insulating film.
摘要翻译： GaN基FET具有大约50nm厚的蓝宝石衬底，其上形成有n型GaN电子传输层和Al 0.2 N高斯0.8 N电子供应层，以及夹在其间的电子传输和供给层的n + + + GaN接触区域。在这些层和区域的整个表面上形成约3000nm厚的聚酰亚胺层间绝缘膜，其形成有形成源极，漏极和栅电极的接触孔，每个都由TaSi / Au层和约5000nm厚度。源电极和漏极电极欧姆连接到n + + + GaN接触区域，并且栅极电极与SiO 2栅极绝缘膜接触。

3. 发明授权

US07612115B2 Aqueous pharmaceutical compositions 有权
标题翻译：水性药物组合物
公开(公告)号：US07612115B2
公开(公告)日：2009-11-03
申请号：US11374450
申请日：2006-03-13
申请人： Hidekazu Suzuki , Takahiro Wada , Masanobu Kirita , Masanobu Takeuchi
发明人： Hidekazu Suzuki , Takahiro Wada , Masanobu Kirita , Masanobu Takeuchi
IPC分类号： A61K47/00 , A61K31/715 , A61K31/47
CPC分类号： A61K31/5383 , A61K9/0048 , A61K47/10 , A61K47/12 , A61K47/38
摘要： The present invention has an object to provide an antibacterial aqueous pharmaceutical composition and an aqueous pharmaceutical composition which have a sufficiently low gelation temperature even when new quinolone antibacterial agents such as ofloxacin as the active ingredient and can be retained at the administration site for a long time by virtue of rapid viscosity increase after administration in spite of their being liquid at administration and thereby attain high availability of pharmaceutical agent.The present invention relates to an antibacterial aqueous pharmaceutical composition which comprises: 2.8 to 4 w/v % of methylcellulose, the 2 w/v % aqueous solution of which has a viscosity of 12 mPa·s or below at 20° C.; 1.5 to 2.3 w/v % of citric acid; 2 to 4 w/v % of polyethylene glycol; and 0.1 to 0.5 w/v % of ofloxacin.
摘要翻译：本发明的目的在于提供一种抗菌水性药物组合物和含水药物组合物，即使新的喹诺酮类抗菌剂如氧氟沙星作为活性成分，也能够在施用部位长时间保留，具有足够低的凝胶化温度由于施用后的粘度快速增加，尽管它们在施用时是液体，从而获得药剂的高可用性。本发明涉及一种抗菌水性药物组合物，其包含：2.8〜4w / v％的甲基纤维素，其2w / v％水溶液在20℃下的粘度为12mPa·s或更低。 1.5至2.3w / v％的柠檬酸; 2至4w / v％的聚乙二醇; 和0.1至0.5w / v％的氧氟沙星。

4. 发明授权

US07450016B2 Driver fatigue assessment device and method 有权
标题翻译：驾驶员疲劳评估装置及方法
公开(公告)号：US07450016B2
公开(公告)日：2008-11-11
申请号：US11295759
申请日：2005-12-07
申请人： Kazuyoshi Isaji , Naohiko Tsuru , Takahiro Wada , Hiroshi Kaneko
发明人： Kazuyoshi Isaji , Naohiko Tsuru , Takahiro Wada , Hiroshi Kaneko
IPC分类号： G08B23/00
CPC分类号： A61B3/113 , A61B5/18 , G06K9/00604 , G06K9/00845 , G08B21/06
摘要： A driver fatigue assessment device may include; a look information generator to generate look information regarding at least one of a driver's direction of a look and a locus at which a driver is looking; a visual stimulator to provide a visual stimulus within a driver's field of view at a first position and then move the location thereof to a second position; a change determination unit to determine whether the look information has changed in response to the movement of the visual stimulus; and a fatigue decision unit to assess driver fatigue based upon an output of the change determination unit.
摘要翻译：驾驶员疲劳评估装置可包括：观看信息发生器，用于产生关于驾驶员的外观方向和驾驶员正在看的轨迹中的至少一个的查看信息; 视觉刺激器，用于在驾驶员的视野内在第一位置处提供视觉刺激，然后将其位置移动到第二位置; 改变确定单元，用于确定所述外观信息是否响应于所述视觉刺激的移动而改变; 以及基于变化确定单元的输出来评估驾驶员疲劳的疲劳判定单元。

5. 发明申请

US20060132319A1 Driver fatigue assessment device and method 有权
标题翻译：驾驶员疲劳评估装置及方法
公开(公告)号：US20060132319A1
公开(公告)日：2006-06-22
申请号：US11295759
申请日：2005-12-07
申请人： Kazuyoshi Isaji , Naohiko Tsuru , Takahiro Wada , Hiroshi Kaneko
发明人： Kazuyoshi Isaji , Naohiko Tsuru , Takahiro Wada , Hiroshi Kaneko
IPC分类号： G08B23/00 , A61B5/00
CPC分类号： A61B3/113 , A61B5/18 , G06K9/00604 , G06K9/00845 , G08B21/06
摘要： A driver fatigue assessment device may include; a look information generator to generate look information regarding at least one of a driver's direction of a look and a locus at which a driver is looking; a visual stimulator to provide a visual stimulus within a driver's field of view at a first position and then move the location thereof to a second position; a change determination unit to determine whether the look information has changed in response to the movement of the visual stimulus; and a fatigue decision unit to assess driver fatigue based upon an output of the change determination unit.
摘要翻译：驾驶员疲劳评估装置可包括：观看信息发生器，用于产生关于驾驶员的外观方向和驾驶员正在看的轨迹中的至少一个的查看信息; 视觉刺激器，用于在驾驶员的视野内在第一位置处提供视觉刺激，然后将其位置移动到第二位置; 改变确定单元，用于确定所述外观信息是否响应于所述视觉刺激的移动而改变; 以及基于变化确定单元的输出来评估驾驶员疲劳的疲劳判定单元。

6. 发明授权

US5169830A Superconducting material 失效
标题翻译：超导材料
公开(公告)号：US5169830A
公开(公告)日：1992-12-08
申请号：US567958
申请日：1990-08-15
申请人： Takahiro Wada , Shinichi Koriyama , Takeshi Sakurai , Nobuo Suzuki , Takayuki Miyatake , Hisao Yamauchi , Naoki Koshizuka , Shoji Tanaka
发明人： Takahiro Wada , Shinichi Koriyama , Takeshi Sakurai , Nobuo Suzuki , Takayuki Miyatake , Hisao Yamauchi , Naoki Koshizuka , Shoji Tanaka
IPC分类号： H01L39/12
CPC分类号： H01L39/126 , Y10S505/778
摘要： A superconductive material is disclosed which has the following composition:(R.sub.1-x Ca.sub.x)(Ba.sub.1-y La.sub.y).sub.2 Cu.sub.4 O.sub.8wherein R is at least one element selected from Y, Nd, Sm, Eu, Gd, Dy, Ho, Er, Tm, Yb and Lu, x is a number in the range of 0-0.3 and y is a number in the range of 0.001-0.3 with the proviso that y is not greater than 0.2 when x is not 0.

7. 发明授权

US4561989A Heat storage material 失效
标题翻译：储热材料
公开(公告)号：US4561989A
公开(公告)日：1985-12-31
申请号：US635578
申请日：1984-07-30
申请人： Takahiro Wada , Ryoichi Yamamoto , Fumiko Yokotani
发明人： Takahiro Wada , Ryoichi Yamamoto , Fumiko Yokotani
IPC分类号： C09K5/06
CPC分类号： C09K5/063
摘要： A heat storage material comprises a sodium acetate-water system containing at least 53-69% by weight sodium acetate (CH.sub.3 CO.sub.2 Na), wherein said heat storage material is mixed with a thickener comprising polyvinyl alcohol, paraffin and one or two components selected from the group consisting of formaldehyde and acetone, and has stable performance and little change of heat storage capacity even under repeated storage and release of heat.
摘要翻译：储热材料包括含有至少53-69％（重量）乙酸钠（CH 3 CO 2 Na）的乙酸钠 - 水体系，其中所述蓄热材料与包含聚乙烯醇，石蜡和一种或两种选自以下组分的组分的增稠剂混合由甲醛和丙酮组成，即使在反复的储存和释放热下也具有稳定的性能和储存能力的变化。

8. 发明授权

US4406804A Heat accumulating material 失效
标题翻译：蓄热材料
公开(公告)号：US4406804A
公开(公告)日：1983-09-27
申请号：US303985
申请日：1981-09-21
申请人： Takahiro Wada , Shoichi Ishihara , Ryoichi Yamamoto
发明人： Takahiro Wada , Shoichi Ishihara , Ryoichi Yamamoto
IPC分类号： C09K5/06 , C09K3/34 , C09K5/00
CPC分类号： C09K5/063
摘要： The heat accumulating material provided according to this invention makes use of the latent heat of fusion of sodium acetate trihydrate, and it comprises, as blended in a system consisting of sodium acetate and water, at least one nucleation catalyst selected from the group of compounds consisting of tetrasodium pyrophosphate, trisodium monohydrogenpyrophosphate, disodium dihydrogenpyrophosphate and monosodium trihydrogenpyrophosphate. In use of this heat accumulating material, the sodium acetate trihydrate would not be overcooled owing to the overcooling preventing function of the nucleation catalyst but is unfailingly crystallized at a temperature close to the fusion point thereof to radiate latent heat of fusion. The overcooling preventing performance of the nucleation catalyst is not deteriorated even if it is subjected to more than 1,000 cycles of repetition of fusion and solidification, and thus the heat accumulating material maintains a very stabilized heat absorbing and radiating capacity.
摘要翻译：根据本发明提供的蓄热材料利用乙酸钠三水合物的融合潜热，并且包括在由乙酸钠和水组成的体系中共混的至少一种成核催化剂，所述成核催化剂选自：焦磷酸四钠，一氢焦磷酸三钠，焦磷酸二氢二钠和焦磷酸三钠。在使用这种蓄热材料时，由于成核催化剂的过冷预防功能，乙酸钠三水合物不会过冷，而是在接近其熔点的温度下不断地结晶，从而辐射潜热融化。成核催化剂的过冷预防性能即使经历1000次以上的熔融和凝固重复循环也不会劣化，因此蓄热材料保持非常稳定的吸热和辐射能力。

9. 发明申请

US20120301673A1 OXIDE FILM, PROCESS FOR PRODUCING SAME, TARGET, AND PROCESS FOR PRODUCING SINTERED OXIDE 审中-公开
标题翻译：氧化膜，其生产方法，目标和生产烧结氧化物的方法
公开(公告)号：US20120301673A1
公开(公告)日：2012-11-29
申请号：US13576567
申请日：2010-12-28
申请人： Seiji Yamazoe , Takahiro Wada
发明人： Seiji Yamazoe , Takahiro Wada
IPC分类号： H01B1/08 , C04B35/64 , C23C14/28 , C23C14/08 , B05D5/12 , B32B3/10 , C23C14/34
CPC分类号： C23C14/3414 , C04B35/495 , C04B2235/3251 , C04B2235/3281 , C04B2235/77 , C23C14/08 , C23C14/28 , Y10T428/24355
摘要： One oxide film of the present invention is a film of an oxide (which can contain incidental impurities) containing one transition element selected from the group consisting of niobium (Nb) and tantalum (Ta) and copper (Cu). The oxide film is an aggregate of microcrystals, an amorphous form including microcrystals or an amorphous form, which shows no clear diffraction peak in an XRD analysis and has p-type conductivity as shown in the chart of FIG. 5 showing the results of XRD (X-ray diffraction) analyses of a first oxide film and a second oxide film. According to this oxide film, p-type conductivity higher than that of a conventional oxide film is obtained. This oxide film is an aggregate of microcrystals, an amorphous form containing microcrystals or an amorphous form, is consequently easily formed on a large substrate, and is therefore suitable also for industrial production.
摘要翻译：本发明的一个氧化物膜是含有选自铌（Nb）和钽（Ta）和铜（Cu）的一种过渡元素的氧化物（其可以含有杂质）的膜。氧化物膜是微晶的集合体，包括微晶或无定形形式的无定形形式，其在XRD分析中没有显示出清晰的衍射峰，并且具有如图5的图表所示的p型电导率。图5示出了第一氧化膜和第二氧化物膜的XRD（X射线衍射）分析的结果。根据该氧化膜，得到比常规氧化物膜高的p型导电性。该氧化物膜是微晶的聚集体，因此容易在大的基材上形成含有微晶或非晶态的无定形形式，因此也适用于工业生产。

10. 发明授权

US6132751A O/W emulsion composition for eye drops 失效
标题翻译：用于滴眼剂的O / W乳液组合物
公开(公告)号：US6132751A
公开(公告)日：2000-10-17
申请号：US150
申请日：1998-02-03
申请人： Hidekazu Suzuki , Satoshi Yamazaki , Yoshikazu Naito , Takahiro Wada , Kaei Nagoshi , Noriko Tahira , Reiko Hirata , Touru Oguma , Makoto Maeda
发明人： Hidekazu Suzuki , Satoshi Yamazaki , Yoshikazu Naito , Takahiro Wada , Kaei Nagoshi , Noriko Tahira , Reiko Hirata , Touru Oguma , Makoto Maeda
IPC分类号： A61K9/00 , A61F2/00 , A61F13/00
CPC分类号： A61K31/573 , A61K9/0048
摘要： An O/W emulsion composition for eye drops comprises a drug selected from the group consisting of fluorometholone, clobetasone butyrate and clobetasol propionate; a phospholipid; liquid paraffine; and water. The O/W emulsion composition is excellent in solubility of fluorometholone, clobetasone butyrate and clobetasol propionate in the tear fluid. Therefore, the composition would exhibit an anti-inflammatory activity identical to or superior to those achieved by the conventional pharmaceutical preparations, by the administration thereof at a dose lower than those for these known drugs. The composition would also be excellent from the economical standpoint and permit reduction of systemic side effects which would be encountered when the conventional drugs are instilled in the eyes.
摘要翻译： PCT No.PCT / JP96 / 02187 Sec。 371日期1998年2月3日 102（e）1998年2月3日PCT PCT 1996年8月5日PCT公布。公开号WO97 / 05882 日期：1997年2月20日用于眼药水的O / W乳液组合物包含选自氟米隆，丁酸氯倍他丁和丙酸氯倍他索的药物; 磷脂; 液体石蜡; 和水。 O / W乳液组合物在泪液中的氟米龙，丁酸氯倍他丁和丙酸氯倍他索的溶解度优异。因此，通过以比这些已知药物低的剂量给药，组合物将表现出与常规药物制剂相同或优于常规药物制剂的抗炎活性。从经济角度看，组合物也是优异的，并且允许减少常规药物滴入眼睛时会遇到的全身副作用。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式